
IntelligenceQ is a company focused on AI-driven solutions for the pharmaceutical and biopharma sectors, aiming to accelerate drug development, enhance innovation, and improve sustainability. Their flagship product, GyaniMed™, is an AI-powered platform designed for scientists, process engineers, and regulatory teams. GyaniMed™ integrates AI agents, knowledge graphs, and retrieval-augmented generation (RAG) to unify fragmented data, optimize manufacturing processes, and ensure regulatory compliance. Key benefits include a 50% faster drug development and tech transfer, 90% accuracy in predicting critical quality attributes, significant annual energy savings per clean-room facility, and 100% regulatory traceability. The platform allows for the integration of proprietary AI models and supports various user groups including pharmaceutical companies, academic institutions, CDMOs, and regulatory teams.

IntelligenceQ is a company focused on AI-driven solutions for the pharmaceutical and biopharma sectors, aiming to accelerate drug development, enhance innovation, and improve sustainability. Their flagship product, GyaniMed™, is an AI-powered platform designed for scientists, process engineers, and regulatory teams. GyaniMed™ integrates AI agents, knowledge graphs, and retrieval-augmented generation (RAG) to unify fragmented data, optimize manufacturing processes, and ensure regulatory compliance. Key benefits include a 50% faster drug development and tech transfer, 90% accuracy in predicting critical quality attributes, significant annual energy savings per clean-room facility, and 100% regulatory traceability. The platform allows for the integration of proprietary AI models and supports various user groups including pharmaceutical companies, academic institutions, CDMOs, and regulatory teams.